about
Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked AdrenoleukodystrophyPeroxisomes in brain development and functionThe genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosisRedox interplay between mitochondria and peroxisomesThe role of microglia in human disease: therapeutic tool or target?Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient miceEvaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy.Loss of AMP-activated protein kinase induces mitochondrial dysfunction and proinflammatory response in unstimulated Abcd1-knockout mice mixed glial cells.Brain endothelial dysfunction in cerebral adrenoleukodystrophy.Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium.25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome.Oxidative Stress in Patients with X-Linked Adrenoleukodystrophy.Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatment.Inherited and acquired disorders of myelin: The underlying myelin pathology.X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.A case of adrenoleukodystrophy presenting with manic symptoms in a patient on steroids for Addison's disease.Yoga as Therapy for Neurodegenerative Disorders: A Case Report of Therapeutic Yoga for Adrenomyeloneuropathy.Defective ABCD1 causes adrenoleukodystrophy (ALD)Eight novel mutations in the ABCD1 gene and clinical characteristics of 25 Chinese patients with X-linked adrenoleukodystrophy.Microglial dysfunction as a key pathological change in adrenomyeloneuropathy.ABCD1 dysfunction alters white matter microvascular perfusion.A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.Childhood cerebral X-linked adrenoleukodystrophy with atypical neuroimaging abnormalities and a novel mutation.Inflammatory profile in X-linked adrenoleukodystrophy patients: Understanding disease progression.Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.Therapeutic strategies in adrenoleukodystrophy.[Overview of X-linked adrenoleukodystrophy in Morocco: results of the implementation of the program of clinical and biological diagnosis].Leukodystrophy: Basic and Clinical.Modeling and rescue of defective blood-brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients.PEX5 regulates autophagy via the mTORC1-TFEB axis during starvation.Anaesthetic management of a child with adrenoleukodystrophy: A case report
P2860
Q26750155-F6B956D1-C261-41A4-9F9A-79EF53DE2388Q26774697-2BC82279-0473-44A7-8EC4-AF5B50B373E9Q26829999-12C870D5-7162-4740-8C03-59FD511C6D44Q28394944-5BC7E8F2-1FFD-4F69-9122-7EE112F23CA9Q34038205-CBF6EDC0-0CB3-488A-A794-6A7D9C320661Q34257373-7A9BB45F-337B-42E3-8254-3270306FC11CQ35216369-4414C41A-E135-444C-9033-589F8B7C402CQ35227024-94832A50-B91C-43F4-AE9C-D442C54FD614Q36515946-262441CD-03D7-4341-BC80-98B4B1D7D8FCQ37042656-A03C7586-F477-4639-8499-D6E66D8721B3Q37389923-247C69F2-416F-4F7D-A860-AA16FB892977Q38546277-7293B1A3-C191-465D-9678-031EB884508CQ38751654-2ADE1E97-F90B-4911-9948-20CFAD940164Q38805611-BAAA03E1-6420-4FFA-8C32-FE76A4716353Q38806290-141A0DAC-276F-4C5F-94FE-87243151891DQ39679149-8E000827-CA2B-44F0-9B1A-8CC94797503DQ42327773-09BC1A56-3676-43C4-816D-A2DA99EAF13FQ43123516-E973B96C-5C44-4222-9A3F-1CFD25177A06Q45314466-C235FAE0-2DE9-4A99-8F01-586D80138A3EQ46656602-7161BC5C-85EB-466E-90D8-149E19A41BB6Q47135502-EF889325-B726-4BED-8AF4-383178563150Q47405028-1CE93D1C-7382-420C-AC01-34AB648B0275Q47801072-74FBFABD-DBC4-42D2-AEFB-7ABBAE753AD9Q47828070-66CFBFB7-DE13-4181-9958-75B426D0A31EQ48102083-1EC33673-8B96-44DB-9D7E-C75C0E00205BQ48925414-02698E73-4C40-4E38-AD75-A02ABBDFC6E7Q51009080-7DD4C860-820C-48FF-BCE5-3B367B188338Q52620446-AA6CF916-3C3E-4619-8166-A694529DEE99Q53180871-441A1BC4-C606-4D63-88EA-51C29EE3B620Q55055706-10561B17-1F3E-48AC-8F7F-6592DE92C731Q55285407-2A1E3E3D-ABE5-4D1D-BE4E-25089365B9B0Q58805677-2FCB514B-96D2-4364-AFE7-1D21A55D76D9
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pathophysiology of X-linked adrenoleukodystrophy.
@ast
Pathophysiology of X-linked adrenoleukodystrophy.
@en
Pathophysiology of X-linked adrenoleukodystrophy.
@nl
type
label
Pathophysiology of X-linked adrenoleukodystrophy.
@ast
Pathophysiology of X-linked adrenoleukodystrophy.
@en
Pathophysiology of X-linked adrenoleukodystrophy.
@nl
prefLabel
Pathophysiology of X-linked adrenoleukodystrophy.
@ast
Pathophysiology of X-linked adrenoleukodystrophy.
@en
Pathophysiology of X-linked adrenoleukodystrophy.
@nl
P2860
P921
P1433
P1476
Pathophysiology of X-linked adrenoleukodystrophy.
@en
P2093
F S Eichler
S Forss-Petter
P2860
P304
P356
10.1016/J.BIOCHI.2013.11.023
P5008
P577
2013-12-04T00:00:00Z
2014-03-01T00:00:00Z